ʻO Candida Albicans Nucleic Acid

ʻO Candida ka mea kanu maʻamau maʻamau maʻamau i loko o ke kino o ke kanaka, aia nui i loko o ka ʻōpū hanu, digestive tract, genitourinary tract a me nā mea ʻē aʻe e kamaʻilio me ka honua o waho. ʻAʻole ia he pathogenic maʻamau a pili i ka bacteria pathogenic conditional. Ma muli o ka hoʻohana nui ʻana o ka immunosuppressive agents, ka ulu ʻana o ka radiotherapy tumor, chemotherapy, invasive treatment, a me ka hoʻololi ʻana o ke kino, a me ka hoʻohana nui ʻana o ka nui o nā lāʻau lapaʻau ākea ākea, lilo ka flora maʻamau i mea ʻole, e alakaʻi ana i nā maʻi Candida i ka ʻāpana genitourinary a me ka ʻōpū hanu.

ʻO ka maʻi Candida i loko o ka ʻāpana genitourinary hiki ke hoʻopilikia i nā wahine i ka candidal vulvitis a me ka vaginitis, a e hoʻopilikia i nā kāne i ka candidal balanitis, acroposthitis a me prostatitis, e hoʻopilikia nui i ke ola a me ka hana o nā maʻi. Ke piʻi nei ka nui o ka maʻi candidiasis genital tract i kēlā me kēia makahiki. Ma waena o lākou, ʻo nā maʻi maʻi candida wahine ma kahi o 36%, a ʻo nā kāne ma kahi o 9%, a ʻo nā maʻi Candida albicans (CA) ka mea nui, e pili ana i ka 80%.

ʻO ka maʻi fungal maʻamau o ka maʻi Candida albicans kahi kumu nui o ka make mai nā maʻi nosocomial. Ma waena o nā maʻi maʻi koʻikoʻi i ka ICU, ʻo Candida albicans ka maʻi ma kahi o 40%. Ma waena o nā maʻi fungal visceral a pau, ʻo nā maʻi fungal pulmonary ka nui a ke piʻi nei lākou i kēlā me kēia makahiki. ʻO ka ʻike mua a me ka ʻike ʻana i nā maʻi fungal pulmonary he koʻikoʻi koʻikoʻi koʻikoʻi.

ʻO nā hōʻike lapaʻau o kēia manawa o Candida albicans genotypes ka nui o ka ʻano A, ʻano B, a me ke ʻano C, a ʻo ia mau genotypes ʻekolu no ka 90%. ʻO ka hōʻoia pololei o ka maʻi Candida albicans hiki ke hāʻawi i nā hōʻike no ka hōʻoia a me ka mālama ʻana i ka vulvitis candidal a me ka vaginitis, ka balanitis candidal kāne, acroposthitis a me prostatitis, a me ka maʻi hanu Candida albicans maʻi.